HLS Therapeutics Inc.
HLS Therapeutics Inc. (HLS.TO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HLS.TO · as of Jun 8, 2026
Key Statistics
Explore HLS Therapeutics Inc. Data
hls.to stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 0.0%
Competitors & Peers
hls.to competitorsHLS.TO
BNXT.CN
CRDL.TO
GRIN.CN
HBP.TO
JUSH.CNStock Performance
Full HistoryAbout HLS Therapeutics Inc.
HLS Therapeutics Inc. a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular (CV) markets in Canada, the Un…
what is hls therapeutics inc. · hls.to stock overview · hls therapeutics inc. company profile · who is hls therapeutics inc. ceo · hls.to TSX · hls therapeutics inc. headquarters · hls therapeutics inc. business segments
About Stock Overview & Key Data
HLS Therapeutics Inc. (HLS.TO) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on TSX since Mar 14, 2018. As of the latest trading session, HLS.TO stock price is $4.47, with a market capitalization of $139.8M. The stock has returned -10.24% over the past 12 months and -7.26% year-to-date.
According to 1 Wall Street analysts, the consensus rating for HLS Therapeutics Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, HLS Therapeutics Inc. reported revenue of $56.5M and net income of -$12.6M. For detailed data — including HLS Therapeutics Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, HLS Therapeutics Inc. (HLS.TO) stock price is $4.47. The stock is traded on TSX under the ticker symbol HLS.TO. The 52-week range is $0.00 – $5.76.